GlassScriptPhysician profile
Bennett Roman
NPI 1164877478
$1,558.26
in general payments reported to CMS, 2019-2025
9 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.80 · 2023: $113 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $878 · Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $878.09 |
| Food and Beverage | $594.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,055.71 | 2025 | Triclip |
| Heron Therapeutics, INC. | $170.35 | 2025 | Aponvie, Zynrelef |
| Abiomed | $112.78 | 2023 | Impella |
| Edwards Lifesciences Corporation | $71.66 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $54.10 | 2022-2025 | Iovera, Exparel |
| Atricure, INC. | $32.41 | 2025 | Atriclip Laa Exclusion System |
| Conmed Corporation | $26.19 | 2025 | Airseal |
| Fisher & Paykel Healthcare INC | $18.15 | 2025 | Fisher & Paykel Healthcare |
| Merck Sharp & Dohme LLC | $16.91 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.